Healthcare -
Biotechnology - NASDAQ - US
$ 1.755
1.45 %
$ 267 M
Market Cap
-10.97
P/E
HRTX - DEPRECIATION & AMORTIZATION
Depreciation & Amortization HRTX - Heron Therapeutics, Inc.
2.9 M
LAST VALUE
-2.04%
2 YEAR CAGR
13.89%
5 YEAR CAGR
24.16%
10 YEAR CAGR